您的位置: 首页 > 农业专利 > 详情页

3 - (1 - {3 - [5 - (1-methyl-piperidin-4-ilmeroxi) - pyridine-2-il) - 3 - (1 - {3 - [5 - (1-methyl-piperidin-4-ilmeroxi) - benil} - 6-oxo-1, 6-dihydro-piridizin-3-il) - benzoic acid and its preparation
专利权人:
MERCK PATENT GMBH
发明人:
BECKER, AXEL,KUEHN, CLEMENS,SAAL, CHRISTOPH,SCHADT, OLIVER,DORSCH, DIETER,BOKEL, HEINZ-HERMANN,STIEBER, FRANK,DONINI, CHRISTINA
申请号:
PE2013002901
公开号:
PE20141317A1
申请日:
2009.12.04
申请国别(地区):
PE
年份:
2014
代理人:
摘要:
2.5, 14.5, 2.5.2.5, 14.5.5, 14.2.5, 14.2.5, 14.2.5, 14.2.5, 14.nf3 The peak value of cu-ka1 activity expressed in 2 theta + / -0.1 is 6.0, 9.9, 12.8, 15.7, 16.3, 16.9, 20.3, etc.; and (c) the peak value of cu-ka1 activity XRD expressed in 2 theta + / -0.1 is 10.1, 10.8, 11.6, 13.0, 13.5, 15.4, 17.8, etc,There are others He also mentioned a preparatory process and a pharmacology composer. These crystalline forms are useful tools for cancer treatmentSE REFIERE A FORMAS CRISTALINAS DEL CLORHIDRATO DE 3-(1-{3-[5-(1-METIL-PIPERIDIN-4-ILMETOXI)-PIRIMIDIN-2-IL]-BENCIL}-6-OXO-1,6-DIHIDRO-PIRIDAZIN-3-IL)-BENZONITRILO TALES COMO: A) LA FORMA H1 CUYOS PICOS XRD USANDO RADIACION Cu-Ka1 EXPRESADOS EN GRADOS 2 THETA +/- 0,1� SON 5.9, 8.8, 11.3, 12.2, 14.5, 15.2, 16.0, ENTRE OTROS; B) LA FORMA NF3 CUYOS PICOS XRD USANDO RADIACION Cu-Ka1 EXPRESADOS EN GRADOS 2 THETA +/- 0,1� SON 6.0, 9.9, 12.8, 15.7, 16.3, 16.9, 20.3, ENTRE OTROS; Y C) LA FORMA H2 CUYOS PICOS XRD USANDO RADIACION Cu-Ka1 EXPRESADOS EN GRADOS 2 THETA +/- 0,1� SON 10.1, 10.8, 11.6, 13.0, 13.5, 15.4, 17.8, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCESO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHAS FORMAS CRISTALINAS SON UTILES EN EL TRATAMIENTO DE CANCER
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充